Literature DB >> 11575976

Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases.

M Fraquelli1, A Losco, S Visentin, B M Cesana, R Pometta, A Colli, D Conte.   

Abstract

BACKGROUND: The reported prevalence of gallstone disease (GD), defined as current gallstones or previous cholecystectomy for gallstones, in patients with Crohn disease ranges from 13% to 34%. The aim of this study was to characterize the still undefined risk factors of this complication.
METHODS: A total of 330 consecutive patients with Crohn disease (189 males and 141 females aged 17-82 years, mean +/- SD age, 41 +/- 14 years) underwent liver ultrasonography.
RESULTS: A diagnosis of GD was made in 78 patients (24%), 54 with current gallstones and 24 who had undergone previous cholecystectomy. Its frequency was comparable in males and females (23% vs 25%), but was significantly associated with age (P =.001), being 13%, 36%, and 51% in patients aged 44 years and younger, 45 to 59 years, and 60 years and older, respectively (P =.001). Its prevalence significantly differed according to the site of the disease at diagnosis (P =.02) and was unrelated to disease duration. Gallstone disease was more frequent in patients who had undergone surgery (34% vs 14%; P =.001) and was significantly associated with the number (P =.001) and site of bowel resections (P =.001), increasing from 28% in the patients who had undergone 1 resection to 53% in those having had 2 or more resections (P =.005) and being significantly higher in patients with a resection involving the ileocecal region. Multivariate analysis showed that age; site of disease at diagnosis; and the presence, number, and site of bowel resections were significantly related to GD.
CONCLUSIONS: In patients with Crohn disease, the frequency of GD is significantly higher than that reported in the general population with comparable characteristics (z = 5.04, P<.001). Age; site of disease at diagnosis; and the history, number, and site of bowel resections are independently associated with GD.

Entities:  

Mesh:

Year:  2001        PMID: 11575976     DOI: 10.1001/archinte.161.18.2201

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

1.  Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based study.

Authors:  Gaurav Arora; Gurkirpal Singh; Shweta Vadhavkar; Shamita B Shah; Ajitha Mannalithara; Alka Mithal; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2010-04-29       Impact factor: 3.199

Review 2.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

3.  Isolated involvement of the gallbladder by Crohn's disease manifesting as acute cholecystitis.

Authors:  Ajay Kumar Sharma; Ibrahim M Nawroz; Nicholas Evgenikos; Thomas Daniel
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

4.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

5.  Small-bowel obstruction associated with Crohn's enterolith.

Authors:  Anuj Tewari; Jason Weiden; Jamlik-Omari Johnson
Journal:  Emerg Radiol       Date:  2013-02-08

6.  Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease.

Authors:  Wolfgang Kratzer; Mark-M Haenle; Richard-A Mason; Christian von Tirpitz; Volker Kaechele
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

7.  Gallbladder bile composition in patients with Crohn 's disease.

Authors:  Annika Lapidus; Jan-Erik Akerlund; Curt Einarsson
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

8.  T-cell function is critical for murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Varada P Rao; Zhongming Ge; Arlin B Rogers; Trisha J Oura; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

Review 9.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

10.  Liver disorders in inflammatory bowel disease.

Authors:  Victor Uko; Suraj Thangada; Kadakkal Radhakrishnan
Journal:  Gastroenterol Res Pract       Date:  2012-02-15       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.